These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5129617)

  • 1. Glucagon in the treatment of Paget's disease of bone.
    Condon JR
    Br Med J; 1971 Dec; 4(5789):719-21. PubMed ID: 5129617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
    Condon JR; Surtees J; Robinson V
    Postgrad Med J; 1981 Feb; 57(664):84-8. PubMed ID: 6455656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-protamine-glucagon in the treatment of Paget's disease of bone. Preliminary report.
    Christiansen C; Tonnesen KH
    Acta Med Scand; 1974 Dec; 196(6):495-6. PubMed ID: 4456980
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of bone: problems and management.
    Haddad JG
    Orthop Clin North Am; 1972 Nov; 3(3):775-86. PubMed ID: 4344935
    [No Abstract]   [Full Text] [Related]  

  • 6. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
    Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
    Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
    [No Abstract]   [Full Text] [Related]  

  • 7. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
    Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta.
    Goldfield EB; Braiker BM; Prendergast JJ; Kolb FO
    JAMA; 1972 Sep; 221(10):1127-9. PubMed ID: 4679000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease].
    Lo Cascio V; Lechi C; Adami S; Bianchi I; Cominacini L; Galvanini G
    Boll Soc Ital Biol Sper; 1974 Jan; 50(1-2):55-61. PubMed ID: 4425587
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M; Siris ES; Lyles KW; Knieriem A; Newton RA; Schaffer V; Zelenakas K
    Calcif Tissue Int; 1997 May; 60(5):415-8. PubMed ID: 9115157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of bone turnover in Paget's disease.
    Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
    Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
    [No Abstract]   [Full Text] [Related]  

  • 15. Human calcitonin in the treatment of Paget's bone disease.
    Woodhouse NJ; Bordier P; Fisher M; Joplin GF; Reiner M; Kalu DN; Foster GV; MacIntyre I
    Lancet; 1971 Jun; 1(7710):1139-43. PubMed ID: 4102856
    [No Abstract]   [Full Text] [Related]  

  • 16. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S; Massie JD; Postlethwaite AE; Palmieri GM
    Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 19. [Short term treatment of Paget's disease with porcine calcitonin].
    Renier JC; Boasson M; Jallet P; Bernat M
    Rev Rhum Mal Osteoartic; 1973 Oct; 40(10):557-63. PubMed ID: 4797550
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.